The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma Source: Eur Respir J 2013; 41: 943-951 Year: 2013
Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Immunohistochemical staining in detection and localization of mycobacterial tuberculosis in human histological samples (preliminary report) Source: Eur Respir J 2007; 30: Suppl. 51, 196s Year: 2007
An immunohistochemistry (IHC) assessemnt of NSCLC cases Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma Source: Eur Respir J 2007; 30: Suppl. 51, 290s Year: 2007
Differential diagnostics of pulmonary TB and tumors in bronchial biopsy using cytologic methods Source: Eur Respir J 2007; 30: Suppl. 51, 662s Year: 2007
Histological, histochemical and immunohistochemical study on pulmonary hamartoma. Case report Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Potential prognostic factors in typical and atypical carcinoid tumours of the lung - immunhistochemical investigations Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology Source: Eur Respir Mon; 2010: 48: 272–296 Year: 2010
Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Clinicopathologic features, histologic and immunohistochemical characteristics, and clinical outcome of patients with cardiac myofibroblastic tumors Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
Karyometric analysis of pulmonary neuroendocrine tumors Source: Eur Respir J 2002; 20: Suppl. 38, 71s Year: 2002
Typical pulmonary carcinoid tumors: presentation, diagnosis and outcome in 24 cases Source: Eur Respir J 2004; 24: Suppl. 48, 532s Year: 2004
Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential Source: Eur Respir J 2001; 18: Suppl. 33, 19s Year: 2001
The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002
Quick immunohistochemical diagnosis of neoplasia pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 581s Year: 2006